Syncfusion Presents Essential Studio 2024 Volume 1
RESEARCH TRIANGLE PARK, N.C., April 10, 2024 (GLOBE NEWSWIRE) -- Syncfusion, Inc., the enterprise technology partner of choice, announces the ...
Read moreRESEARCH TRIANGLE PARK, N.C., April 10, 2024 (GLOBE NEWSWIRE) -- Syncfusion, Inc., the enterprise technology partner of choice, announces the ...
Read moreNewly Branded Global Channel with 300,000+ Subscribers Pays Tribute to Stan Lee, Offering Exclusive Content from and Inspired by the ...
Read moreHELSINKI, Finland, April 10, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies presented promising ...
Read more- Pre-clinical results demonstrate the combination of FMC-376 with PD-1 immunotherapy increases survival and response rates compared to PD-1 alone ...
Read more100% reduction of target lesions in one melanoma and one pancreatic cancer patient observed among 4 Partial Responses (PR) to ...
Read morePoster outlines the parameters for developing a flow-cytometry-based PPMP as a companion diagnostic to predict volasertib responders, based on a ...
Read moreMDNA113 is targeted to the tumor site where it is activated to simultaneously deliver two immunotherapies, an IL-2 superkine and ...
Read moreVANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse ...
Read moreReal-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLC Emerging data show non-classical EGFR ...
Read moreWATERTOWN, Mass. and GOSSELIES, Belgium, April 07, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.